연구동향 분석

ATP-Based Chemotherapy Response Assay in Primary or Recurrent Ovarian and Peritoneal Cancer

이마리아 김성훈 김상운 남은지 조한별 김재훈 김영태 2014년

논문상세정보
인용/피인용
' ATP-Based Chemotherapy Response Assay in Primary or Recurrent Ovarian and Peritoneal Cancer' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • adenosinetriphosphate
  • cell death
  • combination
  • drug therapy
  • ovarian cancer
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,824 0

0.0%

' ATP-Based Chemotherapy Response Assay in Primary or Recurrent Ovarian and Peritoneal Cancer' 의 참고문헌

  • The use of an in vitro adenosine triphosphate-based chemotherapy response assay to predict chemotherapeutic response in breast cancer
    Kim HA BREAST 17 : 19 ~ 26 [2008]
  • The use of an in vitro adenosine triphosphate-based chemotherapy response assay to predict chemotherapeutic response in breast cancer
    Kim HA BREAST 17 19-26 [2008]
  • Semi-micro adaptation of a 4-day differential staining cytotoxicity (DiSC) assay for determining the in-vitro chemosensitivity of haematological malignancies
    Bird MC Leuk Res 10 : 445 ~ 449 [1986]
  • Semi-micro adaptation of a 4-day differential staining cytotoxicity (DiSC) assay for determining the in-vitro chemosensitivity of haematological malignancies
    Bird MC Leuk Res 10 445-449 [1986]
  • Primary bioassay of human tumor stem cells
    Hamburger AW Science 197 : 461 ~ 463 [1977]
  • Primary bioassay of human tumor stem cells
    Hamburger AW Science 197 461-463 [1977]
  • Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer
    O’Meara AT Gynecol Oncol 83 : 334 ~ 342 [2001]
  • Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer
    O’Meara AT Gynecol Oncol 83 334-342 [2001]
  • Predictive value of individualized tumor response testing by ATP-based chemotherapy response assay in ovarian cancer
    Han SS CANCER INVESTIGATION 26 : 426 ~ 430 [2008]
  • Predictive value of individualized tumor response testing by ATP-based chemotherapy response assay in ovarian cancer
    Han SS CANCER INVESTIGATION 26 426-430 [2008]
  • Paclitaxel-ifosfamide-cisplatin as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and paclitaxel
    Polyzos A Anticancer Res 27 : 1645 ~ 1651 [2007]
  • Paclitaxel-ifosfamide-cisplatin as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and paclitaxel
    Polyzos A Anticancer Res 27 1645-1651 [2007]
  • Laboratory detection of primary and acquired drug resistance in human lymphatic neoplasms
    Weisenthal LM Cancer Treat Rep 70 : 1283 ~ 1295 [1986]
  • Laboratory detection of primary and acquired drug resistance in human lymphatic neoplasms
    Weisenthal LM Cancer Treat Rep 70 1283-1295 [1986]
  • Individualizing chemotherapy for solid tumors--is there any alternative?
    Cree IA Anticancer Drugs 8 : 541 ~ 548 [1997]
  • Individualizing chemotherapy for solid tumors--is there any alternative?
    Cree IA Anticancer Drugs 8 541-548 [1997]
  • In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions
    Pieters R Blood 76 : 2327 ~ 2336 [1990]
  • In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions
    Pieters R Blood 76 2327-2336 [1990]
  • In vitro determination of tumour chemosensitivity in haematological malignancies
    Bird MC Hematol Oncol 3 : 1 ~ 10 [1985]
  • In vitro determination of tumour chemosensitivity in haematological malignancies
    Bird MC Hematol Oncol 3 1-10 [1985]
  • Ifosfamide, paclitaxel and cisplatin first-line chemotherapy in advanced, suboptimally debulked epithelial ovarian cancer
    Papadimitriou CA Cancer 92 : 1856 ~ 1863 [2001]
  • Ifosfamide, paclitaxel and cisplatin first-line chemotherapy in advanced, suboptimally debulked epithelial ovarian cancer
    Papadimitriou CA Cancer 92 1856-1863 [2001]
  • First-line intraperitoneal cisplatin-paclitaxel and intravenous ifosfamide in Stage IIIc ovarian epithelial cancer
    Zylberberg B Eur J Gynaecol Oncol 25 : 327 ~ 332 [2004]
  • First-line intraperitoneal cisplatin-paclitaxel and intravenous ifosfamide in Stage IIIc ovarian epithelial cancer
    Zylberberg B Eur J Gynaecol Oncol 25 327-332 [2004]
  • Development of a miniaturized, improved nucleic acid precursor incorporation assay for chemosensitivity testing of human solid tumors
    Kern DH Cancer Res 45 (11 Pt) : 5436 ~ 5441 [1985]
  • Development of a miniaturized, improved nucleic acid precursor incorporation assay for chemosensitivity testing of human solid tumors
    Kern DH Cancer Res 45 11 Pt 5436-5441 [1985]
  • Detection of tumor cells in blood using CD45 magnetic cell separation followed by nested mutant allele-specific amplification of p53 and K-ras genes in patients with colorectal cancer
    Iinuma H Int J Cancer 89 : 337 ~ 344 [2000]
  • Detection of tumor cells in blood using CD45 magnetic cell separation followed by nested mutant allele-specific amplification of p53 and K-ras genes in patients with colorectal cancer
    Iinuma H Int J Cancer 89 337-344 [2000]
  • Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma
    Andreotti PE Cancer Res 55 : 5276 ~ 5282 [1995]
  • Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma
    Andreotti PE Cancer Res 55 5276-5282 [1995]
  • Application of an ATP-bioluminescence assay in human tumor chemosensitivity testing
    Sevin BU Gynecol Oncol 31 : 191 ~ 204 [1988]
  • Application of an ATP-bioluminescence assay in human tumor chemosensitivity testing
    Sevin BU Gynecol Oncol 31 191-204 [1988]
  • Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided platinum-based 2-drug chemotherapy for unresectable nonsmall-cell lung cancer
    Moon YW CANCER 109 : 1829 ~ 1835 [2007]
  • Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided platinum-based 2-drug chemotherapy for unresectable nonsmall-cell lung cancer
    Moon YW CANCER 109 1829-1835 [2007]
  • A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis
    Fruscio R Br J Cancer 98 : 720 ~ 727 [2008]
  • A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis
    Fruscio R Br J Cancer 98 720-727 [2008]
  • A Feasibility Study of Adenosine Triphosphate-based Chemotherapy Response Assay (ATP-CRA) as a Chemosensitivity Test for Lung Cancer
    Shin Myung Kang Cancer Research and Treatment 37 (4) : 223 ~ 227 [2005]
  • A Feasibility Study of Adenosine Triphosphate-based Chemotherapy Response Assay (ATP-CRA) as a Chemosensitivity Test for Lung Cancer
    Shin Myung Kang Cancer Research and Treatment 37 4 223-227 [2005]